GLP-1 drugs such as Ozempic, Wegovy, and Zepbound may increase hair-loss risk by 7% in men who are already genetically susceptible to male-pattern baldness. The findings suggest thinning hair may not be caused only by rapid weight loss and could also reflect a biological link between GLP-1 activity and hair follicles.
Source: https://www.sciencedaily.com/releases/2 ... 214241.htm
Source: https://www.sciencedaily.com/releases/2 ... 214241.htm
